Efficient Publication Strategy Leads to Expedited Submission and Acceptance Case study Since the World Health Organization (WHO) launched the Global…

Navigating the latest ICH E8(R1) Guideline Revisions Becoming fully compliant with the latest and soon-to-be released ICH E8(R1) guidance documents…

RBQM for Decentralized Trials: Two key areas of focus to reduce your risk Since ICH-GCP E6 R2 made Risk-Based Quality…

Aixial FSP models: Expand your data management and biostatistics capabilities Whatever your existing study team structure and study data output…

Data Science & Analytics Data science and analytics solutions to fit your needs perfectly. Enhance the power of your trials…

Our experience in First-In-Human and Early Phase Oncology Trials Overview of Aixial Group’s in-depth experience in the areas of First-In-…

Top 10 Things to Look for in a Specialist Data & Analytics CRO Partner This helpful resource takes the guess…

Expert Medical Writing For Your Every Need Our medical writing experts can help you tailor a complete range of regulatory…

Commitment to Patient Centricity and Diversity: Key ingredients for a successful trial November marks the start of Movember, an annual…

Omicron Presents New Challenges for Early Phase Trials The evolving coronavirus disease 2019 (COVID-19) pandemic continues to present challenges for…

How to report clinical trials affected by the COVID-19 pandemic: Dealing with extraordinary circumstances Since 2020, the COVID-19 pandemic has…

Flexibility and Speed In Early Phase Clinical Trials Written by Crista Casey, Executive VP Global Head of Operations First and…